Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Eliana Merle's Stock Ratings
UBS Analyst
Eliana Merle is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
11.5%
Smart Score
Overall Average Return Percentile
61st
Number of Ratings
113
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/23/2025 | MRNA | Buy Now | Moderna | $29.95 | 33.56% | $70 → $40 | Maintains | Buy | Get Alert | |
| 09/12/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | 10.96% | $72 → $82 | Maintains | Buy | Get Alert | |
| 09/10/2025 | GOSS | Buy Now | Gossamer Bio | $3.88 | 131.96% | $1.25 → $9 | Upgrade | Neutral → Buy | Get Alert | |
| 08/13/2025 | ALT | Buy Now | Altimmune | $5.31 | 351.98% | $26 → $24 | Maintains | Buy | Get Alert | |
| 08/12/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | -70.01% | $8 → $9 | Maintains | Neutral | Get Alert | |
| 08/12/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -6.7% | $458 → $523 | Maintains | Buy | Get Alert | |
| 08/12/2025 | ANAB | Buy Now | AnaptysBio | $47.63 | -58.01% | $18 → $20 | Maintains | Neutral | Get Alert | |
| 08/08/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | 43.97% | $306 → $307 | Maintains | Buy | Get Alert | |
| 08/05/2025 | BMRN | Buy Now | BioMarin Pharmaceutical | $52.23 | 118.27% | $113 → $114 | Maintains | Buy | Get Alert | |
| 08/01/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | 40.49% | $403 → $550 | Maintains | Buy | Get Alert | |
| 07/21/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | -44.03% | $45 → $12 | Downgrade | Buy → Neutral | Get Alert | |
| 07/15/2025 | PROK | Buy Now | ProKidney | $2.10 | 280.95% | $4 → $8 | Maintains | Buy | Get Alert | |
| 06/26/2025 | CVAC | Buy Now | CureVac | $5.00 | 10% | $12 → $5.5 | Downgrade | Buy → Neutral | Get Alert | |
| 05/22/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | -96.67% | $2 → $1 | Maintains | Neutral | Get Alert | |
| 05/15/2025 | ARVN | Buy Now | Arvinas | $12.26 | 71.29% | $74 → $21 | Maintains | Buy | Get Alert | |
| 05/13/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -18.3% | $72 → $70 | Maintains | Buy | Get Alert | |
| 05/02/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -10.86% | $331 → $349 | Maintains | Buy | Get Alert | |
| 05/02/2025 | MRNA | Buy Now | Moderna | $29.95 | 133.72% | $78 → $70 | Maintains | Buy | Get Alert | |
| 05/02/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -18.29% | $441 → $458 | Maintains | Buy | Get Alert | |
| 04/30/2025 | CVAC | Buy Now | CureVac | $5.00 | 140% | $13 → $12 | Maintains | Buy | Get Alert | |
| 04/30/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -2.57% | $65 → $72 | Maintains | Buy | Get Alert | |
| 04/29/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 79.23% | → $44 | Initiates | → Overweight | Get Alert | |
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 116.35% | $109 → $113 | Maintains | Buy | Get Alert | |
| 02/19/2025 | MRNA | Buy Now | Moderna | $29.95 | 160.43% | $96 → $78 | Maintains | Buy | Get Alert | |
| 01/31/2025 | ETNB | Buy Now | 89bio | — | — | $25 → $38 | Maintains | Buy | Get Alert | |
| 01/31/2025 | AKRO | Buy Now | Akero Therapeutics | $54.70 | 99.27% | $42 → $109 | Maintains | Buy | Get Alert | |
| 01/28/2025 | ZNTL | Buy Now | Zentalis Pharma | $1.43 | 53.84% | $5 → $2.2 | Maintains | Neutral | Get Alert | |
| 01/08/2025 | RVMD | Buy Now | Revolution Medicines | $77.51 | -8.4% | $65 → $71 | Maintains | Buy | Get Alert | |
| 01/08/2025 | MRNA | Buy Now | Moderna | $29.95 | 220.53% | $108 → $96 | Maintains | Buy | Get Alert | |
| 01/07/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | -8.08% | → $196 | Initiates | → Buy | Get Alert | |
| 01/07/2025 | TYRA | Buy Now | Tyra Biosciences | $22.12 | 26.58% | → $28 | Initiates | → Buy | Get Alert | |
| 11/12/2024 | SGMT | Buy Now | Sagimet Biosciences | $6.03 | 99% | → $12 | Initiates | → Buy | Get Alert | |
| 11/12/2024 | IVA | Buy Now | Inventiva | $4.48 | -33.04% | → $3 | Initiates | → Neutral | Get Alert | |
| 11/12/2024 | ALT | Buy Now | Altimmune | $5.31 | 389.64% | → $26 | Initiates | → Buy | Get Alert | |
| 11/04/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -13.63% | $80 → $74 | Maintains | Buy | Get Alert | |
| 11/01/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -21.33% | $411 → $441 | Maintains | Buy | Get Alert | |
| 10/31/2024 | ARVN | Buy Now | Arvinas | $12.26 | 503.59% | $82 → $74 | Maintains | Buy | Get Alert | |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 102.95% | $104 → $106 | Maintains | Buy | Get Alert | |
| 10/30/2024 | ANAB | Buy Now | AnaptysBio | $47.63 | -30.72% | $23 → $33 | Maintains | Neutral | Get Alert | |
| 10/24/2024 | MRNA | Buy Now | Moderna | $29.95 | 260.6% | $140 → $108 | Maintains | Buy | Get Alert | |
| 09/18/2024 | BNTX | Buy Now | BioNTech | $93.87 | 39.55% | $97 → $131 | Maintains | Neutral | Get Alert | |
| 09/09/2024 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | -93.34% | $10 → $2 | Maintains | Neutral | Get Alert | |
| 08/09/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 238.09% | $85 → $83 | Maintains | Buy | Get Alert | |
| 06/28/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -26.44% | $253 → $288 | Maintains | Buy | Get Alert | |
| 06/20/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.43 | 249.63% | $28 → $5 | Downgrade | Buy → Neutral | Get Alert | |
| 05/28/2024 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -36.4% | $51 → $47 | Maintains | Buy | Get Alert | |
| 05/08/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 246.23% | $89 → $85 | Maintains | Buy | Get Alert | |
| 05/07/2024 | MRNA | Buy Now | Moderna | $29.95 | 404.17% | $143 → $151 | Maintains | Buy | Get Alert | |
| 04/04/2024 | KOD | Buy Now | Kodiak Sciences | $21.50 | -76.74% | $3 → $5 | Maintains | Neutral | Get Alert | |
| 03/27/2024 | TERN | Buy Now | Terns Pharma | $45.50 | -60.44% | $19 → $18 | Maintains | Buy | Get Alert | |
| 03/27/2024 | BNTX | Buy Now | BioNTech | $93.87 | 7.6% | $110 → $101 | Maintains | Neutral | Get Alert | |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -26.86% | $337 → $410 | Maintains | Buy | Get Alert | |
| 03/05/2024 | AKRO | Buy Now | Akero Therapeutics | $54.70 | -23.22% | $39 → $42 | Maintains | Buy | Get Alert | |
| 03/04/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 262.53% | $87 → $89 | Maintains | Buy | Get Alert | |
| 02/22/2024 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | -66.68% | $61 → $10 | Downgrade | Buy → Neutral | Get Alert | |
| 02/14/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $25 → $32.5 | Downgrade | Buy → Neutral | Get Alert | |
| 12/21/2023 | KOD | Buy Now | Kodiak Sciences | $21.50 | -86.05% | $4 → $3 | Maintains | Neutral | Get Alert | |
| 12/20/2023 | RVMD | Buy Now | Revolution Medicines | $77.51 | -48.39% | → $40 | Initiates | → Buy | Get Alert | |
| 11/02/2023 | ANAB | Buy Now | AnaptysBio | $47.63 | -55.91% | $28 → $21 | Maintains | Neutral | Get Alert | |
| 10/12/2023 | ETNB | Buy Now | 89bio | — | — | $36 → $25 | Maintains | Buy | Get Alert | |
| 10/12/2023 | AKRO | Buy Now | Akero Therapeutics | $54.70 | -28.7% | $83 → $39 | Maintains | Buy | Get Alert | |
| 09/26/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $18 → $25 | Maintains | Buy | Get Alert | |
| 08/28/2023 | ETNB | Buy Now | 89bio | — | — | → $36 | Initiates | → Buy | Get Alert | |
| 08/28/2023 | AKRO | Buy Now | Akero Therapeutics | $54.70 | 51.74% | → $83 | Initiates | → Buy | Get Alert | |
| 08/23/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 160.69% | $60 → $64 | Maintains | Buy | Get Alert | |
| 08/14/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 07/27/2023 | KOD | Buy Now | Kodiak Sciences | $21.50 | -81.4% | $15 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 06/26/2023 | MRNA | Buy Now | Moderna | $29.95 | 537.73% | $221 → $191 | Upgrade | Neutral → Buy | Get Alert | |
| 05/19/2023 | QURE | Buy Now | uniQure | $23.00 | 82.61% | $45 → $42 | Maintains | Buy | Get Alert | |
| 05/17/2023 | ARVN | Buy Now | Arvinas | $12.26 | 634.09% | $151 → $90 | Maintains | Buy | Get Alert | |
| 05/03/2023 | ISEE | Buy Now | IVERIC bio | — | — | $34 → $40 | Downgrade | Buy → Neutral | Get Alert | |
| 03/31/2023 | BNTX | Buy Now | BioNTech | $93.87 | 62.99% | $168 → $153 | Maintains | Neutral | Get Alert | |
| 02/07/2023 | TERN | Buy Now | Terns Pharma | $45.50 | -58.24% | → $19 | Initiates | → Buy | Get Alert | |
| 01/19/2023 | CVAC | Buy Now | CureVac | $5.00 | 260% | → $18 | Upgrade | Neutral → Buy | Get Alert | |
| 12/21/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -39.88% | $161 → $337 | Maintains | Buy | Get Alert | |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $3.88 | 106.19% | $19 → $8 | Maintains | Buy | Get Alert | |
| 11/23/2022 | QURE | Buy Now | uniQure | $23.00 | 82.61% | $40 → $42 | Maintains | Buy | Get Alert | |
| 10/13/2022 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.31 | 34.85% | → $22 | Initiates | → Buy | Get Alert | |
| 08/02/2022 | ISEE | Buy Now | IVERIC bio | — | — | → $20 | Initiates | → Buy | Get Alert | |
| 06/23/2022 | RGNX | Buy Now | Regenxbio | $13.83 | 239.84% | $51 → $47 | Maintains | Buy | Get Alert | |
| 04/06/2022 | GOSS | Buy Now | Gossamer Bio | $3.88 | 389.69% | → $19 | Initiates | → Buy | Get Alert | |
| 03/17/2022 | QURE | Buy Now | uniQure | $23.00 | 73.91% | → $40 | Upgrade | Neutral → Buy | Get Alert | |
| 01/21/2022 | MRNA | Buy Now | Moderna | $29.95 | 637.9% | → $221 | Initiates | → Neutral | Get Alert | |
| 08/27/2021 | BNTX | Buy Now | BioNTech | $93.87 | 219.59% | $111 → $300 | Maintains | Neutral | Get Alert | |
| 05/21/2021 | KDMN | Buy Now | Kadmon Holdings | — | — | → $9 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | FOLD | Buy Now | Amicus Therapeutics | $10.76 | 48.7% | → $16 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -6.63% | → $80 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | ZNTL | Buy Now | Zentalis Pharma | $1.43 | 6263.19% | → $91 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 234.01% | → $82 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | QURE | Buy Now | uniQure | $23.00 | 73.91% | → $40 | Initiates | → Neutral | Get Alert | |
| 05/21/2021 | ANAB | Buy Now | AnaptysBio | $47.63 | -39.11% | → $29 | Initiates | → Neutral | Get Alert | |
| 05/21/2021 | ARVN | Buy Now | Arvinas | $12.26 | 903.26% | → $123 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | 8.25% | → $80 | Initiates | → Buy | Get Alert | |
| 09/29/2020 | ZNTL | Buy Now | Zentalis Pharma | $1.43 | 2976.71% | → $44 | Initiates | → Overweight | Get Alert | |
| 08/19/2020 | GLPG | Buy Now | Galapagos | $31.11 | 330.73% | $192 → $134 | Maintains | Neutral | Get Alert | |
| 08/04/2020 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $15 → $20 | Maintains | Overweight | Get Alert | |
| 05/12/2020 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $5 → $15 | Reiterates | → Overweight | Get Alert | |
| 04/28/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 148.47% | $54 → $61 | Maintains | Overweight | Get Alert | |
| 04/28/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | → $121 | Initiates | → Neutral | Get Alert | |
| 03/13/2020 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $2 → $5 | Upgrade | Neutral → Overweight | Get Alert | |
| 02/25/2020 | GLPG | Buy Now | Galapagos | $31.11 | 517.16% | $187 → $192 | Downgrade | Overweight → Neutral | Get Alert | |
| 02/04/2020 | FOLD | Buy Now | Amicus Therapeutics | $10.76 | 85.87% | $19 → $20 | Assumes | → Overweight | Get Alert | |
| 01/29/2020 | SELB | Buy Now | Selecta Biosciences | — | — | → $10 | Initiates | → Overweight | Get Alert | |
| 01/22/2020 | BNTX | Buy Now | BioNTech | $93.87 | -62.71% | $21 → $35 | Downgrade | Buy → Neutral | Get Alert | |
| 12/20/2019 | ARVN | Buy Now | Arvinas | $12.26 | 511.75% | $42 → $75 | Reiterates | → Overweight | Get Alert | |
| 11/26/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 11/25/2019 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 119.96% | $50 → $54 | Reiterates | → Overweight | Get Alert | |
| 11/04/2019 | BNTX | Buy Now | BioNTech | $93.87 | -77.63% | → $21 | Initiates | → Buy | Get Alert | |
| 08/06/2019 | ARVN | Buy Now | Arvinas | $12.26 | 242.58% | → $42 | Initiates | → Overweight | Get Alert | |
| 12/19/2018 | GLPG | Buy Now | Galapagos | $31.11 | 317.87% | → $130 | Initiates | → Overweight | Get Alert | |
| 10/22/2018 | TSRO | Buy Now | Tesaro | — | — | $57 → $68 | Maintains | Overweight | Get Alert | |
| 10/01/2018 | TSRO | Buy Now | Tesaro | — | — | → $57 | Initiates | → Overweight | Get Alert | |
| 08/28/2018 | ANAB | Buy Now | AnaptysBio | $47.63 | 160.34% | → $124 | Initiates | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved